Antigen peptide transporter 1 is involved in the development of fructose-induced hepatic steatosis in mice-Reference-Cited by-同舟云学术

Antigen peptide transporter 1 is involved in the development of fructose-induced hepatic steatosis in mice

Published:2013-07-22 Issue:8 Volume:28 Page:1403-1409
ISSN:0815-9319
Container-title:Journal of Gastroenterology and Hepatology
language:en
Short-container-title:J Gastroenterol Hepatol

Author:

Arindkar Shailendra¹,Bhattacharjee Jashdeep¹,Kumar Jerald Mahesh²,Das Barun¹,Upadhyay Pramod¹,Asif Shajahan¹,Juyal Ramesh C¹,Majumdar Subeer S¹,Perumal Nagarajan¹

Affiliation:

1. National Institute of Immunology; New Delhi India

2. CSIR-Centre for Cellular and Molecular Biology; Hyderabad India

Funder

Department of Biotechnology, India

Publisher

Wiley

Subject

Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jgh.12186/fullpdf

Reference22 articles.

1. Genetically modified mouse models for the study of nonalcoholic fatty liver disease;Nagarajan;World J. Gastroenterol.,2012

2. Role of the inducible nitric oxide synthase in the onset of fructose-induced steatosis in mice;Spruss;Antioxid. Redox Signal.,2011

3. Nonalcoholic fatty liver disease in humans is associated with increased plasma endotoxin and plasminogen activator inhibitor 1 concentrations and with fructose intake;Thuy;J. Nutr.,2008

4. Fructose consumption as a risk Factor for non-alcoholic fatty liver disease;Ouyang;J. Hepatol.,2008

5. Antibiotics protect against fructose-induced hepatic lipid accumulation in mice: role of endotoxin;Bergheim;J. Hepatol.,2008

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impacts of small-molecule STAT3 inhibitor SC-43 on toxicity, global proteomics and metabolomics of HepG2 cells;Journal of Pharmaceutical and Biomedical Analysis;2024-05

2. Myeloid cell MHC I expression drives CD8+ T cell activation in nonalcoholic steatohepatitis;Frontiers in Immunology;2024-01-11

3. State of CD8+ T cells in progression from nonalcoholic steatohepatitis to hepatocellular carcinoma: From pathogenesis to immunotherapy;Biomedicine & Pharmacotherapy;2023-09

4. Decoding the role of immune T cells: A new territory for improvement of metabolic‐associated fatty liver disease;iMeta;2023-01-18

5. Crucial role of T cells in NAFLD-related disease: A review and prospect;Frontiers in Endocrinology;2022-11-15